These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5023690)

  • 1. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
    Cohen MH
    J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.
    Cohen MH; Carbone PP
    J Natl Cancer Inst; 1972 Apr; 48(4):921-6. PubMed ID: 5023689
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine.
    Cohen MH
    J Pharmacol Exp Ther; 1975 Sep; 194(3):475-9. PubMed ID: 240017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW; Humphrey EW
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract]   [Full Text] [Related]  

  • 5. Brief communication: Enhancement of the antitumor effect of 1,-3-bis(2-chloroethyl)-1-nitrosourea by chlorpromazine and caffeine.
    Cohen MH
    J Natl Cancer Inst; 1973 Oct; 51(4):1323-5. PubMed ID: 4745861
    [No Abstract]   [Full Text] [Related]  

  • 6. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD; Kline I; Venditti JM; Goldin A
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomal potentiation of the antitumor activity of alkylating drugs.
    Rutman RJ; Ritter CA; Avadhani NG; Hansel J
    Cancer Treat Rep; 1976 May; 60(5):617-8. PubMed ID: 991151
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
    Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
    August EM; Prusoff WH
    Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
    Olshin S; Siddiqui S; Firat D
    Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of the anticancer activity of bis(2-chloroethyl)nitrosourea in mice by coadministration of 2'-deoxyuridine, 2'-deoxycytidine, or thymidine.
    Lin TS; Prusoff WH
    Cancer Res; 1987 Jan; 47(2):394-7. PubMed ID: 3791229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
    Venditti JM; Kline I; Tyrer DD; Goldin A
    Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic antileukemic effect of theophylline and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    DeWys WD; Bathina SH
    Cancer Res; 1980 Jul; 40(7):2202-8. PubMed ID: 6248198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds upon the synthesis of DNA by cell-free systems.
    Wheeler GP; Bowdon BJ
    Cancer Res; 1968 Jan; 28(1):52-9. PubMed ID: 5635372
    [No Abstract]   [Full Text] [Related]  

  • 19. Some effects of 1, 3-bis(2-chloroethyl)-1-nitrosourea upon the synthesis of protein and nucleic acids in vivo and in vitro.
    Wheeler GP; Bowdon BJ
    Cancer Res; 1965 Nov; 25(10):1770-8. PubMed ID: 5859203
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.